Clinical benefit from resection of recurrent glioblastomas: Results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Florian Ringel - , Technical University of Munich (Author)
  • Haiko Pape - , Technical University of Munich (Author)
  • Michael Sabel - , Heinrich Heine University Düsseldorf (Author)
  • Dietmar Krex - , Department of Neurosurgery, TUD Dresden University of Technology (Author)
  • Hans Christoph Bock - , University of Göttingen (Author)
  • Martin Misch - , Charité – Universitätsmedizin Berlin (Author)
  • Astrid Weyerbrock - , University of Freiburg (Author)
  • Thomas Westermaier - , University of Würzburg (Author)
  • Christian Senft - , University Hospital Frankfurt (Author)
  • Philippe Schucht - , University of Bern (Author)
  • Bernhard Meyer - , Technical University of Munich (Author)
  • Matthias Simon - , University of Bonn (Author)

Abstract

Background While standards for the treatment of newly diagnosed glioblastomas exist, therapeutic regimens for tumor recurrence remain mostly individualized. The role of a surgical resection of recurrent glioblastomas remains largely unclear at present. This study aimed to assess the effect of repeated resection of recurrent glioblastomas on patient survival. Methods In a multicenter retrospective-design study, patients with primary glioblastomas undergoing repeat resections for recurrent tumors were evaluated for factors affecting survival. Age, Karnofsky performance status (KPS), extent of resection (EOR), tumor location, and complications were assessed. Results Five hundred and three patients (initially diagnosed between 2006 and 2010) undergoing resections for recurrent glioblastoma at 20 institutions were included in the study. The patients' median overall survival after initial diagnosis was 25.0 months and 11.9 months after first re-resection. The following parameters were found to influence survival significantly after first re-resection: preoperative and postoperative KPS, EOR of first re-resection, and chemotherapy after first re-resection. The rate of permanent new deficits after first re-resection was 8%. Conclusion The present study supports the view that surgical resections of recurrent glioblastomas may help to prolong patient survival at an acceptable complication rate.

Details

Original languageEnglish
Pages (from-to)96-104
Number of pages9
JournalNeuro-oncology
Volume18
Issue number1
Publication statusPublished - 1 Jan 2016
Peer-reviewedYes

External IDs

PubMed 26243790

Keywords

Sustainable Development Goals

Keywords

  • glioblastoma, overall survival, recurrent tumor, surgical resection